Status:

UNKNOWN

Screening and Identification of Biomarkers on Cervical Cancers

Lead Sponsor:

National Taiwan University Hospital

Conditions:

Cervical Cancer

Eligibility:

FEMALE

25-80 years

Phase:

NA

Brief Summary

Cervical cancer the most frequent neoplasm and the fifth mortality rate of malignancies of the women in the world. It results in about 1,000 women in Taiwan and about 200,000 women worldwide dying of ...

Eligibility Criteria

Inclusion

  • Healthy volunteers
  • People infected with HPV type 16 but without CIN lesions
  • Patients with CIN lesions
  • Patients with cervical cancer from National Taiwan University Hospital
  • Informed consent is obtained, and the protocols are reviewed and approved by the appropriate Investigative Review Boards.

Exclusion

  • None

Key Trial Info

Start Date :

January 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2011

Estimated Enrollment :

250 Patients enrolled

Trial Details

Trial ID

NCT00854269

Start Date

January 1 2007

End Date

January 1 2011

Last Update

March 24 2009

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan, 100

Screening and Identification of Biomarkers on Cervical Cancers | DecenTrialz